[{"Assets_0_Q3_USD":21968271.0,"CommonStockSharesOutstanding_0_Q3_shares":51509871.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-15992811.0,"NetIncomeLoss_1_Q3_USD":-7074261.0,"NetIncomeLoss_3_Q3_USD":-22415568.0,"StockholdersEquity_0_Q3_USD":17631664.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]